AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10588623 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Lung Volume Reduction Surgery (LVRS)
Number of subjects: 200
Study 10588623 — intervention group
Group type: COMPARATOR
Intervention: Quality of Life (Sickness Impact Profile)
Number of subjects: 200
Study 7486181 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 12
Study 2572248 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 70
Study 2572248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 80 mg
Number of subjects: 70
Study 2572248 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 70
Study 2572248 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 70
Study 2572248 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 70
Study 5571451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine + Entonox
Number of subjects: 152
Study 5571451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine + Trichloroethylene
Number of subjects: 152
Study 5571451 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine alone
Number of subjects: 152
Study 30554749 — intervention group
Group type: EXPERIMENTAL
Intervention: IYCF (20 g of a small‐quantity lipid‐based nutrient supplement per day from age 6 to 18 months plus complementary feeding counselling)
Number of subjects: 3686
Study 30554749 — intervention group
Group type: EXPERIMENTAL
Intervention: IYCF
Number of subjects: 3686
Study 30554749 — intervention group
Group type: COMPARATOR
Intervention: WASH (construction of a ventilated improved pit latrine, provision of two handwashing stations, liquid soap, chlorine, and play space plus hygiene counselling)
Number of subjects: 3686
Study 30554749 — intervention group
Group type: EXPERIMENTAL
Intervention: IYCF plus WASH
Number of subjects: 3686
Study 30554749 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 3686
Study 27625314 — intervention group
Group type: EXPERIMENTAL
Intervention: Slideshows with voice-over
Number of subjects: 1500
Study 27625314 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated videos
Number of subjects: 1500
Study 27625314 — intervention group
Group type: EXPERIMENTAL
Intervention: Comics
Number of subjects: 1500
Study 27625314 — intervention group
Group type: EXPERIMENTAL
Intervention: Text
Number of subjects: 1500
Study 27625314 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 1500
Study 25442673 — intervention group
Group type: EXPERIMENTAL
Intervention: McKenzie techniques
Number of subjects: 70
Study 25442673 — intervention group
Group type: COMPARATOR
Intervention: Motor control exercises
Number of subjects: 70
Study 23674606 — intervention group
Group type: EXPERIMENTAL
Intervention: HFrEx (30% fructose diet with moderate aerobic exercise)
Number of subjects: 8
Study 23674606 — intervention group
Group type: EXPERIMENTAL
Intervention: HFr (30% fructose diet with no exercise)
Number of subjects: 8
Study 23674606 — intervention group
Group type: COMPARATOR
Intervention: C (low fructose diet with no exercise)
Number of subjects: 8
Study 21292262 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic resection (ER) followed by radiofrequency ablation (RFA)
Number of subjects: 26
Study 19972662 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded narrative
Number of subjects: 311
Study 19972662 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional narrative
Number of subjects: 311
Study 19972662 — intervention group
Group type: COMPARATOR
Intervention: Expository
Number of subjects: 311
Study 19972662 — intervention group
Group type: COMPARATOR
Intervention: No viewing
Number of subjects: 311
Study 17554644 — intervention group
Group type: COMPARATOR
Intervention: Music therapy (group A, no pharmacotherapy)
Number of subjects: 641
Study 17554644 — intervention group
Group type: COMPARATOR
Intervention: Music therapy (group B, with pharmacotherapy)
Number of subjects: 641
Study 15525790 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 100
Study 15525790 — intervention group
Group type: COMPARATOR
Intervention: Disulfiram
Number of subjects: 100
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative periportal bupivacaine and intraperitoneal bupivacaine immediately after pneumoperitoneum (Group A)
Number of subjects: 157
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Periportal and intraperitoneal bupivacaine at the end of the operation (Group B)
Number of subjects: 157
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative periportal bupivacaine (Group C)
Number of subjects: 157
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative periportal bupivacaine (Group D)
Number of subjects: 157
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intraperitoneal bupivacaine (Group E)
Number of subjects: 157
Study 11444448 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative intraperitoneal bupivacaine (Group F)
Number of subjects: 157
Study 11444448 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control Group)
Number of subjects: 157
Study 9919837 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncoated theophylline tablet (200 mg, 300 mg dose 5 mg/kg approx) administered orally after 12 hours overnight fasting
Number of subjects: 24
Study 9919837 — intervention group
Group type: COMPARATOR
Intervention: Control group (well-nourished asthma patients)
Number of subjects: 24
Study 9919837 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between undernourished and well-nourished asthma patients
Number of subjects: 24
Study 7850231 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescent method
Number of subjects: 0
Study 7850231 — intervention group
Group type: COMPARATOR
Intervention: Bromocresol purple method
Number of subjects: 0
Study 3299681 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (AF) oral gold
Number of subjects: 0
Study 3299681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29217495 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet oil
Number of subjects: 75
Study 29217495 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond oil
Number of subjects: 75
Study 29217495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 26371345 — intervention group
Group type: EXPERIMENTAL
Intervention: 13.3 mg/24 h rivastigmine patch
Number of subjects: 0
Study 26371345 — intervention group
Group type: COMPARATOR
Intervention: 4.6 mg/24 h rivastigmine patch
Number of subjects: 0
Study 25478898 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 12
Study 22249909 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hyperoxia (FiO2 0.28)
Number of subjects: 16
Study 22249909 — intervention group
Group type: COMPARATOR
Intervention: Control (FiO2 0.21)
Number of subjects: 16
Study 19745744 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year intradialytic exercise training program (group A)
Number of subjects: 44
Study 19745744 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 44
Study 18513359 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 36
Study 18513359 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 36
Study 18513359 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 18513359 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and Placebo
Number of subjects: 36
Study 18513359 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1-Hz HRV index
Number of subjects: 36
Study 18212313 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 206
Study 18212313 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) and androgen suppression therapy (AST) combined
Number of subjects: 206
Study 18212313 — intervention group
Group type: COMPARATOR
Intervention: RT alone in men with no or minimal comorbidity
Number of subjects: 206
Study 18212313 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and AST in men with no or minimal comorbidity
Number of subjects: 206
Study 18212313 — intervention group
Group type: COMPARATOR
Intervention: RT alone in men with moderate or severe comorbidity
Number of subjects: 206
Study 18212313 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and AST in men with moderate or severe comorbidity
Number of subjects: 206
Study 15305182 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐alpha (INFalpha) 2a, 4.5 mega‐units subcutaneously 3 days per week
Number of subjects: 300
Study 15305182 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 300
Study 11404442 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ventromedial prefrontal cortex lesions
Number of subjects: 0
Study 11404442 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with dorsolateral lesions
Number of subjects: 0
Study 11404442 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 11404442 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit measures (questionnaires)
Number of subjects: 0
Study 9348687 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary-signal trials where a fixed primary signal was added to one component of the complex tone.
Number of subjects: 0
Study 9348687 — intervention group
Group type: EXPERIMENTAL
Intervention: Probe signal added to the cued component or to one of three other components in randomized spectral profile trials.
Number of subjects: 0
Study 8325398 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol 0.25%
Number of subjects: 40
Study 8325398 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 40
Study 3518911 — intervention group
Group type: EXPERIMENTAL
Intervention: Amputation
Number of subjects: 211
Study 3518911 — intervention group
Group type: COMPARATOR
Intervention: Limb-sparing procedures plus postoperative radiotherapy
Number of subjects: 211
Study 3518911 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision
Number of subjects: 211
Study 3518911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 211
Study 3518911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy in a randomized trial
Number of subjects: 211
Study 3518911 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention for recurrent disease
Number of subjects: 211
Study 30612202 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (EX-LOG: 40 ± 0.3 au)
Number of subjects: 33
Study 30612202 — intervention group
Group type: COMPARATOR
Intervention: High glycemic index diet (EX-HIG: 80 ± 0.6 au)
Number of subjects: 33
Study 27522095 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot fluoroscopy (SF)
Number of subjects: 35
Study 27522095 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy (CF)
Number of subjects: 35
Study 24990113 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib (Xalkori®)
Number of subjects: 2
Study 24990113 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 2
Study 24990113 — intervention group
Group type: COMPARATOR
Intervention: Formulations (powder in capsule [PIC], immediate-release tablet [IRT], commercial formulated capsule [FC])
Number of subjects: 2
Study 24990113 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 2
Study 22384983 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizing lotion (Cetaphil®) + adapalene gel 0.1%
Number of subjects: 30
Study 22384983 — intervention group
Group type: COMPARATOR
Intervention: Adapalene gel 0.1% only
Number of subjects: 30
Study 20864883 — intervention group
Group type: EXPERIMENTAL
Intervention: MS‐sNT (morphine sulfate and naltrexone hydrochloride extended release capsules)
Number of subjects: 0
Study 20864883 — intervention group
Group type: COMPARATOR
Intervention: KADIAN® (morphine sulfate extended release capsules)
Number of subjects: 0
Study 19769799 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 24
Study 19769799 — intervention group
Group type: COMPARATOR
Intervention: Control acupuncture
Number of subjects: 24
Study 16619656 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 19
Study 16619656 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 19
Study 16619656 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate
Number of subjects: 19
Study 16619656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15134124 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal-direct strategies
Number of subjects: 0
Study 15134124 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal-indirect strategies
Number of subjects: 0
Study 15134124 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonverbal-indirect strategies
Number of subjects: 0
Study 15134124 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive HIV prevention strategies
Number of subjects: 0
Study 11531033 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging shod (with athletic shoes)
Number of subjects: 12
Study 11531033 — intervention group
Group type: COMPARATOR
Intervention: Jogging unshod (barefoot)
Number of subjects: 12
Study 9000664 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA
Number of subjects: 29
Study 9000664 — intervention group
Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 29
Study 9000664 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA 2
Number of subjects: 29
Study 9000664 — intervention group
Group type: COMPARATOR
Intervention: FK506
Number of subjects: 29
Study 7719680 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastromiro
Number of subjects: 150
Study 7719680 — intervention group
Group type: COMPARATOR
Intervention: Urografin 370 (diatrizoate)
Number of subjects: 150
Study 7719680 — intervention group
Group type: COMPARATOR
Intervention: E-Z CAT (barium sulphate)
Number of subjects: 150
Study 2883837 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 5
Study 2883837 — intervention group
Group type: EXPERIMENTAL
Intervention: EA + naloxone (0.8 mg IM)
Number of subjects: 5
Study 2883837 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study 2883837 — intervention group
Group type: EXPERIMENTAL
Intervention: EA + placebo
Number of subjects: 5
Study 29428844 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment; n = 17)
Number of subjects: 84
Study 29428844 — intervention group
Group type: EXPERIMENTAL
Intervention: eCG (300 IU i.m.; n = 17)
Number of subjects: 84
Study 29428844 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 300 (300 IU i.m.; n = 18)
Number of subjects: 84
Study 29428844 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 200 IM (200 IU i.m.; n = 16)
Number of subjects: 84
Study 29428844 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 200 SC (200 IU s.c.; n = 16)
Number of subjects: 84
Study 27632079 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D template model
Number of subjects: 40
Study 27632079 — intervention group
Group type: COMPARATOR
Intervention: 2D template
Number of subjects: 40
Study 24879167 — intervention group
Group type: COMPARATOR
Intervention: Lido-S (lidocaine instillation and saline in the cuff)
Number of subjects: 80
Study 24879167 — intervention group
Group type: COMPARATOR
Intervention: Lido-Lido (lidocaine instillation and lidocaine in the cuff)
Number of subjects: 80
Study 24879167 — intervention group
Group type: COMPARATOR
Intervention: S-S (Saline instillation and saline in the cuff)
Number of subjects: 80
Study 24879167 — intervention group
Group type: COMPARATOR
Intervention: S-Lido (saline instillation and lidocaine in the cuff)
Number of subjects: 80
Study 22817340 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated closed-loop (CL) system started at 18:00 hours
Number of subjects: 8
Study 22817340 — intervention group
Group type: COMPARATOR
Intervention: Automated closed-loop (CL) system started at 21:00 hours
Number of subjects: 8
Study 20053810 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral carotid artery stenting (SBCAS)
Number of subjects: 205
Study 20053810 — intervention group
Group type: COMPARATOR
Intervention: Unilateral carotid artery stenting (CAS)
Number of subjects: 205
Study 20053810 — intervention group
Group type: EXPERIMENTAL
Intervention: SBCAS
Number of subjects: 205
Study 20053810 — intervention group
Group type: COMPARATOR
Intervention: Unilateral CAS
Number of subjects: 205
Study 18678119 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 3 units (600 ml) of fresh frozen plasma (FFP) over 90 minutes
Number of subjects: 109
Study 18678119 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of isotonic saline over 90 minutes
Number of subjects: 109
Study 15601734 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral clicks (0.1 ms, 3 Hz, 70‐100 dB NHL) during steady masseter contraction
Number of subjects: 18
Study 15601734 — intervention group
Group type: EXPERIMENTAL
Intervention: Loud clicks at 100 dB
Number of subjects: 18
Study 15601734 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity clicks
Number of subjects: 18
Study 12133885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic colostrum (20 g daily for 2 weeks)
Number of subjects: 30
Study 12133885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 g maltodextrin daily for 2 weeks)
Number of subjects: 30
Study 10467919 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants prescribed to women with non-cancer pain
Number of subjects: 571
Study 10467919 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial and behavioral characteristics in non-cancer pain patients
Number of subjects: 571
Study 10467919 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain severity, mood, and disability in cancer pain patients
Number of subjects: 571
Study 10467919 — intervention group
Group type: COMPARATOR
Intervention: Comparison of treatment history and current analgesic use in non-cancer pain patients
Number of subjects: 571
Study 10467919 — intervention group
Group type: COMPARATOR
Intervention: Comparison of treatment variables in cancer pain patients
Number of subjects: 571
Study 7783656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 IU/kg/d rHGH
Number of subjects: 60
Study 7783656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 IU/kg/d rHGH
Number of subjects: 60
Study 7783656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 IU/kg/d rHGH
Number of subjects: 60
Study 7783656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 2212391 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C restriction with a daily intake of 25 mg/day (after 3 weeks of low intake)
Number of subjects: 12
Study 2212391 — intervention group
Group type: COMPARATOR
Intervention: Control group with the same diet supplemented with twice the RDA for all vitamins
Number of subjects: 12
Study 627883 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 40 mg/day
Number of subjects: 12
Study 627883 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone 80 mg/day
Number of subjects: 12
Study 627883 — intervention group
Group type: COMPARATOR
Intervention: Heroin (0.214 mg/kg)
Number of subjects: 12
Study 627883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30066392 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 1386
Study 30066392 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 1386
Study 29112070 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG)
Number of subjects: 415
Study 29112070 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted protease inhibitor (PI/r)
Number of subjects: 415
Study 25162212 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 receptor antagonists (IL-2RAs)
Number of subjects: 0
Study 25162212 — intervention group
Group type: COMPARATOR
Intervention: rabbit anti-thymocyte globulin (rATG)
Number of subjects: 0
Study 23511114 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 1306
Study 23511114 — intervention group
Group type: COMPARATOR
Intervention: Scleral buckling (SB)
Number of subjects: 1306
Study 21099672 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 1824
Study 21099672 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 1824
Study 18986600 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb-12)
Number of subjects: 72
Study 18986600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 16895939 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 417
Study 16895939 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of ALT and haemoglobin
Number of subjects: 417
Study 16895939 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearly monitoring of triglycerides, cholesterol, glucose and creatinine
Number of subjects: 417
Study 15523452 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (1 mg/kg)
Number of subjects: 38
Study 15523452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 11718271 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A: DTX (80 mg/m2) followed by VNR (25 mg/m2)
Number of subjects: 23
Study 11718271 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B: VNR (25 mg/m2) followed by DTX (80 mg/m2)
Number of subjects: 23
Study 11718271 — intervention group
Group type: COMPARATOR
Intervention: Protocol A
Number of subjects: 23
Study 11718271 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B
Number of subjects: 23
Study 9850014 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (CEF: cyclophosphamide 500 mg/m2, epirubicin 60 mg/m2, fluorouracil 500 mg/m2)
Number of subjects: 303
Study 9850014 — intervention group
Group type: COMPARATOR
Intervention: Single-agent epirubicin (20 mg/m2) followed by single-agent mitomycin (8 mg/m2)
Number of subjects: 303
Study 9850014 — intervention group
Group type: COMPARATOR
Intervention: Single-agent mitomycin (8 mg/m2)
Number of subjects: 303